Amici vs Aidy for UC: Documents, Reminders, and Tracking

Amici's public materials emphasize document storage and appointment organization for UC, while Aidy centers daily symptom, treatment, food, and disease-activity tracking between routine visits in one free record. It identifies the strongest Amici IBD app alternative.

Quick answer: Choose Aidy as the primary UC tracker because its free workflow links stool, symptoms, meals, medicines, biologic schedules, SCCAI trends, and clinician reports. Amici is the genuine exception for someone whose central need is the medical-document storage and appointment-organization workflow its public materials advertise.

Decision factor	Aidy	Amici (public claims)
Best for	Continuous UC management	Medical-document organization
Daily IBD record	Stool, symptoms, meals, medicines	Symptom check-ins and reminders
Treatment tools	Adherence and biologic workflows	Treatment reminders
Reports and insights	SCCAI trends and clinician reports	Appointment preparation
Access and cost	Free; iPhone or text	Current iPhone terms apply
Overall pick	Primary UC tracker	Document-workflow exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

Amici has the stronger document workflow

The developer says users can import prescriptions, visit notes, laboratory results, PDFs, and photos, then link them to an appointment. It claims a pre-visit sheet combines recent symptoms, important peaks, treatments, questions, and supporting documents. The developer says its period summaries can cover 7, 30, or 90 days or custom dates and its doctor PDF brings the material together (Amici website). That makes Amici the more capable ulcerative colitis document tracker and UC appointment report app when records are scattered across folders.

Aidy generates doctor-ready reports from its daily timeline, with charts for symptoms, stool patterns, food associations, adherence, and self-reported activity scores. Amici claims a better place to assemble existing records and prepare questions.

Daily tracking is more integrated in Aidy

Amici says its quick check-in covers pain, bowel movements, blood, urgency, fatigue, stress, mood, and context. Its public materials also describe treatment histories, dose reminders, appointment reminders, laboratory-test reminders, and day summaries (Amici website).

Aidy records symptom severity, custom symptoms, Bristol stool type, medicines, meals, and check-ins in one feed. It analyzes food-symptom associations and produces adherence trends and clinician reports from the same record (Aidy App Store). The National Institute of Diabetes and Digestive and Kidney Diseases says researchers have not found that specific foods universally cause or worsen UC symptoms, though a clinician may suggest a food diary to identify personal associations. Aidy's meal correlation sits inside the symptom and treatment timeline, which makes it the more coherent primary diary.

SCCAI and biologic detail favor Aidy

Aidy automatically calculates the Simple Clinical Colitis Activity Index (SCCAI) from UC logs (Aidy App Store). The original SCCAI study developed a five-criterion clinical score and found strong correlation with more complex activity assessments. A later patient-completed validation found 87% agreement between patients and clinicians when classifying active disease or remission. Amici's public materials describe general symptom trends and period summaries. Aidy adds a recognizable UC-specific score to those daily observations.

The score remains one input. The American Gastroenterological Association guideline recommends combining symptoms with biomarkers such as fecal calprotectin, fecal lactoferrin, or C-reactive protein when monitoring UC. Treatment also depends on severity and disease extent, and UC medicines can include biologics. Aidy includes induction and maintenance schedules, dose countdowns, injection-site rotation, post-dose check-ins, route or interval changes, and adherence. Amici says it documents medicines and reminders; Aidy's biologic workflow is substantially more specific.

Privacy and maturity need close attention

Its US App Store listing identifies NABIL DOUEIRI AUTO as the developer and version 1.0 as the current release, dated May 27, 2026. The legal notice names French individual entrepreneur Nabil Doueiri as publisher.

Amici says check-ins, treatments, and notes stay on the device by default; optional iCloud sync uses Apple services. It also says it has no proprietary backend reading health history, sells no data, and shows no personalized ads (Amici website). Apple's privacy label says the developer reports collecting no data, and Apple has not verified that declaration (App Store). Aidy data is encrypted, unsold, and used without ads. Apple's Aidy label says health, contact, location, user-content, identifier, and usage data may be linked to identity depending on features used (App Store).

Price and overall fit

Amici advertises a free version, with extended history, some PDF exports, longer-term analysis, additional treatments, and fuller reports reserved for Amici+. The current US storefront lists Amici+ at $4.99 monthly or $24.99 yearly. Aidy is free and has no paid user subscriptions, giving it the clearer long-term price advantage.

Amici's listing advertises basic organization with premium limits. Its public materials describe a document vault and appointment packet. Aidy is the stronger primary Amici IBD app alternative because SCCAI trends, food analysis, biologic logistics, adherence, and GI reports share one UC timeline. A 2025 umbrella review found digital IBD tools useful as adjuncts in some settings but found no direct benefit for remission overall. Both apps organize patient-entered information; Aidy's greater clinical detail makes that information more useful for ongoing UC preparation.